Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Hairy Cell 2Hodgkin Disease 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Sarcoma, Myeloid 1Sarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Myeloproliferative Disorders 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1

Interventions

Temozolomide 10Radiotherapy 4Bevacizumab 4etoposide phosphate 3Surgical Procedures, Operative 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Perfusion Magnetic Resonance Imaging 2O(6)-benzylguanine 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gadolinium DTPA 2Filgrastim 2Erlotinib Hydrochloride 2Dynamic Contrast Enhanced Magnetic Resonance Imaging 2Dexamethasone 2Congresses as Topic 2Carboplatin 2Calcium Dobesilate 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vocimagene amiretrorepvec 1varlilumab 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1talampanel 1sodium thiosulfate 1selinexor 1sargramostim 1regadenoson 1poly ICLC 1plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oligodendroglioma × plerixafor × Clear all
NCT01339039 2017-11-17

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Dana-Farber Cancer Institute

Phase 1 Terminated
26 enrolled
CNS

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡